Global Implantable Neurostimulation Devices Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Implantable Neurostimulation Devices Market Size, Manufacturers, Opportunities and Forecast to 2030


Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

According to APO Research, The global Implantable Neurostimulation Devices market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

Global Implantable Neurostimulation Devices key players include Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share over 80%, followed by Europe, and Asia (Ex.China), both have a share about 10 percent.

In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%. And in terms of application, the largest application is Pain Management, followed by Parkinson’s Disease, Epilepsy, Urinary and Fecal Incontinence, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Implantable Neurostimulation Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Neurostimulation Devices.

The Implantable Neurostimulation Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Implantable Neurostimulation Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Medtronic
Boston Scientific
St. Jude Medical (Abbott)
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical

Implantable Neurostimulation Devices segment by Type

Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Others

Implantable Neurostimulation Devices segment by Application

Pain Management
Parkinson's Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Others

Implantable Neurostimulation Devices Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Neurostimulation Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Implantable Neurostimulation Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Neurostimulation Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Implantable Neurostimulation Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Implantable Neurostimulation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Implantable Neurostimulation Devices Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Implantable Neurostimulation Devices Sales Estimates and Forecasts (2019-2030)
1.3 Implantable Neurostimulation Devices Market by Type
1.3.1 Spinal Cord Stimulation (SCS)
1.3.2 Gastric Electric Stimulation (GES)
1.3.3 Deep Brain Stimulation (DBS)
1.3.4 Sacral Nerve Stimulation (SNS)
1.3.5 Vagus Nerve Stimulation (VNS)
1.3.6 Others
1.4 Global Implantable Neurostimulation Devices Market Size by Type
1.4.1 Global Implantable Neurostimulation Devices Market Size Overview by Type (2019-2030)
1.4.2 Global Implantable Neurostimulation Devices Historic Market Size Review by Type (2019-2024)
1.4.3 Global Implantable Neurostimulation Devices Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Implantable Neurostimulation Devices Sales Breakdown by Type (2019-2024)
1.5.2 Europe Implantable Neurostimulation Devices Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Implantable Neurostimulation Devices Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Implantable Neurostimulation Devices Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Implantable Neurostimulation Devices Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Implantable Neurostimulation Devices Industry Trends
2.2 Implantable Neurostimulation Devices Industry Drivers
2.3 Implantable Neurostimulation Devices Industry Opportunities and Challenges
2.4 Implantable Neurostimulation Devices Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Implantable Neurostimulation Devices Revenue (2019-2024)
3.2 Global Top Players by Implantable Neurostimulation Devices Sales (2019-2024)
3.3 Global Top Players by Implantable Neurostimulation Devices Price (2019-2024)
3.4 Global Implantable Neurostimulation Devices Industry Company Ranking, 20
22 VS 2023 VS 2024
3.5 Global Implantable Neurostimulation Devices Key Company Manufacturing Sites & Headquarters
3.6 Global Implantable Neurostimulation Devices Company, Product Type & Application
3.7 Global Implantable Neurostimulation Devices Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Implantable Neurostimulation Devices Market CR5 and HHI
3.8.2 Global Top 5 and
10 Implantable Neurostimulation Devices Players Market Share by Revenue in 2023
3.8.3 20
23 Implantable Neurostimulation Devices Tier 1, Tier 2, and Tier 3
4 Implantable Neurostimulation Devices Regional Status and Outlook
4.1 Global Implantable Neurostimulation Devices Market Size and CAGR by Region: 20
19 VS 2023 VS 2030
4.2 Global Implantable Neurostimulation Devices Historic Market Size by Region
4.2.1 Global Implantable Neurostimulation Devices Sales in Volume by Region (2019-2024)
4.2.2 Global Implantable Neurostimulation Devices Sales in Value by Region (2019-2024)
4.2.3 Global Implantable Neurostimulation Devices Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Implantable Neurostimulation Devices Forecasted Market Size by Region
4.3.1 Global Implantable Neurostimulation Devices Sales in Volume by Region (2025-2030)
4.3.2 Global Implantable Neurostimulation Devices Sales in Value by Region (2025-2030)
4.3.3 Global Implantable Neurostimulation Devices Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Implantable Neurostimulation Devices by Application
5.1 Implantable Neurostimulation Devices Market by Application
5.1.1 Pain Management
5.1.2 Parkinson's Disease
5.1.3 Urinary and Fecal Incontinence
5.1.4 Epilepsy
5.1.5 Gastroparesis
5.1.6 Others
5.2 Global Implantable Neurostimulation Devices Market Size by Application
5.2.1 Global Implantable Neurostimulation Devices Market Size Overview by Application (2019-2030)
5.2.2 Global Implantable Neurostimulation Devices Historic Market Size Review by Application (2019-2024)
5.2.3 Global Implantable Neurostimulation Devices Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Implantable Neurostimulation Devices Sales Breakdown by Application (2019-2024)
5.3.2 Europe Implantable Neurostimulation Devices Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Implantable Neurostimulation Devices Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Implantable Neurostimulation Devices Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Implantable Neurostimulation Devices Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Medtronic
6.1.1 Medtronic Comapny Information
6.1.2 Medtronic Business Overview
6.1.3 Medtronic Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Implantable Neurostimulation Devices Product Portfolio
6.1.5 Medtronic Recent Developments
6.2 Boston Scientific
6.2.1 Boston Scientific Comapny Information
6.2.2 Boston Scientific Business Overview
6.2.3 Boston Scientific Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Implantable Neurostimulation Devices Product Portfolio
6.2.5 Boston Scientific Recent Developments
6.3 St. Jude Medical (Abbott)
6.3.1 St. Jude Medical (Abbott) Comapny Information
6.3.2 St. Jude Medical (Abbott) Business Overview
6.3.3 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Product Portfolio
6.3.5 St. Jude Medical (Abbott) Recent Developments
6.4 LivaNova
6.4.1 LivaNova Comapny Information
6.4.2 LivaNova Business Overview
6.4.3 LivaNova Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LivaNova Implantable Neurostimulation Devices Product Portfolio
6.4.5 LivaNova Recent Developments
6.5 Nevro
6.5.1 Nevro Comapny Information
6.5.2 Nevro Business Overview
6.5.3 Nevro Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nevro Implantable Neurostimulation Devices Product Portfolio
6.5.5 Nevro Recent Developments
6.6 NeuroPace
6.6.1 NeuroPace Comapny Information
6.6.2 NeuroPace Business Overview
6.6.3 NeuroPace Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 NeuroPace Implantable Neurostimulation Devices Product Portfolio
6.6.5 NeuroPace Recent Developments
6.7 Beijing Pins
6.7.1 Beijing Pins Comapny Information
6.7.2 Beijing Pins Business Overview
6.7.3 Beijing Pins Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Beijing Pins Implantable Neurostimulation Devices Product Portfolio
6.7.5 Beijing Pins Recent Developments
6.8 Synapse Biomedical
6.8.1 Synapse Biomedical Comapny Information
6.8.2 Synapse Biomedical Business Overview
6.8.3 Synapse Biomedical Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Synapse Biomedical Implantable Neurostimulation Devices Product Portfolio
6.8.5 Synapse Biomedical Recent Developments
7 North America by Country
7.1 North America Implantable Neurostimulation Devices Sales by Country
7.1.1 North America Implantable Neurostimulation Devices Sales Growth Rate (CAGR) by Country: 20
19 VS 2023 VS 2030
7.1.2 North America Implantable Neurostimulation Devices Sales by Country (2019-2024)
7.1.3 North America Implantable Neurostimulation Devices Sales Forecast by Country (2025-2030)
7.2 North America Implantable Neurostimulation Devices Market Size by Country
7.2.1 North America Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 20
19 VS 2023 VS 2030
7.2.2 North America Implantable Neurostimulation Devices Market Size by Country (2019-2024)
7.2.3 North America Implantable Neurostimulation Devices Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Implantable Neurostimulation Devices Sales by Country
8.1.1 Europe Implantable Neurostimulation Devices Sales Growth Rate (CAGR) by Country: 20
19 VS 2023 VS 2030
8.1.2 Europe Implantable Neurostimulation Devices Sales by Country (2019-2024)
8.1.3 Europe Implantable Neurostimulation Devices Sales Forecast by Country (2025-2030)
8.2 Europe Implantable Neurostimulation Devices Market Size by Country
8.2.1 Europe Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 20
19 VS 2023 VS 2030
8.2.2 Europe Implantable Neurostimulation Devices Market Size by Country (2019-2024)
8.2.3 Europe Implantable Neurostimulation Devices Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Implantable Neurostimulation Devices Sales by Country
9.1.1 Asia-Pacific Implantable Neurostimulation Devices Sales Growth Rate (CAGR) by Country: 20
19 VS 2023 VS 2030
9.1.2 Asia-Pacific Implantable Neurostimulation Devices Sales by Country (2019-2024)
9.1.3 Asia-Pacific Implantable Neurostimulation Devices Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Implantable Neurostimulation Devices Market Size by Country
9.2.1 Asia-Pacific Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 20
19 VS 2023 VS 2030
9.2.2 Asia-Pacific Implantable Neurostimulation Devices Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Implantable Neurostimulation Devices Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Implantable Neurostimulation Devices Sales by Country
10.1.1 Latin America Implantable Neurostimulation Devices Sales Growth Rate (CAGR) by Country: 20
19 VS 2023 VS 2030
10.1.2 Latin America Implantable Neurostimulation Devices Sales by Country (2019-2024)
10.1.3 Latin America Implantable Neurostimulation Devices Sales Forecast by Country (2025-2030)
10.2 Latin America Implantable Neurostimulation Devices Market Size by Country
10.2.1 Latin America Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 20
19 VS 2023 VS 2030
10.2.2 Latin America Implantable Neurostimulation Devices Market Size by Country (2019-2024)
10.2.3 Latin America Implantable Neurostimulation Devices Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Implantable Neurostimulation Devices Sales by Country
11.1.1 Middle East and Africa Implantable Neurostimulation Devices Sales Growth Rate (CAGR) by Country: 20
19 VS 2023 VS 2030
11.1.2 Middle East and Africa Implantable Neurostimulation Devices Sales by Country (2019-2024)
11.1.3 Middle East and Africa Implantable Neurostimulation Devices Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Implantable Neurostimulation Devices Market Size by Country
11.2.1 Middle East and Africa Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 20
19 VS 2023 VS 2030
11.2.2 Middle East and Africa Implantable Neurostimulation Devices Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Implantable Neurostimulation Devices Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Implantable Neurostimulation Devices Value Chain Analysis
12.1.1 Implantable Neurostimulation Devices Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Implantable Neurostimulation Devices Production Mode & Process
12.2 Implantable Neurostimulation Devices Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Implantable Neurostimulation Devices Distributors
12.2.3 Implantable Neurostimulation Devices Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings